Delivery Order SPE2DR25D3012-SPE2DR26F4B8D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,179.35 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,255.04 to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,030.34 to AmerisourceBergen Drug Corp for the supply of CREXONT ER 87.5 MG-350 MG capsules (120 count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, issued under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,272.44 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Crexont ER 70 mg-280 mg capsules (120-count). This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $6,966.32 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg–210 mg capsules (120 count). The contract, executed on October 27, 2025, with an ultimate completion date of October 28, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,851.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for CREXONT ER 87.5 MG-350 MG capsules (120-count supply). This non-set-aside competitive award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $6,461.53 to AmerisourceBergen Drug Corp for Crexont ER (52.5 mg-210 mg capsules, quantity 120) with a firm fixed price contract type. The award, issued on October 31, 2025, is non-competitive with an ultimate completion date of November 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count) on May 20, 2025, with a ceiling value of $2,394.89 and firm fixed pricing. This competitive award, which carries no set-aside designation, is classified as a child contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement transaction under the...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4B8DDelivery Order
The Defense Logistics Agency awarded a $1,539.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CREXONT ER 70 MG-280 MG capsules (120-count) on November 14, 2025, with completion scheduled for November 17, 2025. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for CREXONT represents a routine pharmaceutical supply fulfillment within AmerisourceBergen's established federal contracting relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/14/25 |